cd133 1 apc Search Results


apc conjugated anti human cd133 1  (Miltenyi Biotec)
95
Miltenyi Biotec apc conjugated anti human cd133 1
Antibodies used for flow cytometry experiments.
Apc Conjugated Anti Human Cd133 1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/CD133%2F1+Antibody%2C+anti-human/pmc03997403-1-3-7
Average 95 stars, based on 1 article reviews
apc conjugated anti human cd133 1 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
human cd133 apc-conjugated antibody  (Bio-Techne corporation)
94
Bio-Techne corporation human cd133 apc-conjugated antibody
Antibodies used for flow cytometry experiments.
Human Cd133 Apc Conjugated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/Human+CD133+APC-conjugated+Antibody/bio-techne+corporation___fab11331a
Average 94 stars, based on 1 article reviews
human cd133 apc-conjugated antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
cd133  (R&D Systems)
93
R&D Systems cd133
Antibodies used for flow cytometry experiments.
Cd133, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/Human+CD133+APC-conjugated+Antibody/pmc02795856-39-19-20
Average 93 stars, based on 1 article reviews
cd133 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
rea820  (Miltenyi Biotec)
91
Miltenyi Biotec rea820
Antibodies used for flow cytometry experiments.
Rea820, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/CD133%2F2+Antibody%2C+anti-human%2C+REAfinity/10__21203_slash_rs__3__rs___549885_slash_v1-587-9-10
Average 91 stars, based on 1 article reviews
rea820 - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
anti-human cd133 apc antibody  (Becton Dickinson)
90
Becton Dickinson anti-human cd133 apc antibody
Examination of the relationship between different circulating progenitor or mature endothelial cells and the risk of AD/dementia by using Cox proportional hazards regression models after adjusting for covariates
Anti Human Cd133 Apc Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/facsaria/pmc11160969-120-32-36
Average 90 stars, based on 1 article reviews
anti-human cd133 apc antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
human recombinant monoclonal anti cd133 1 rea753 miltenyi biotec  (Miltenyi Biotec)
95
Miltenyi Biotec human recombinant monoclonal anti cd133 1 rea753 miltenyi biotec
Examination of the relationship between different circulating progenitor or mature endothelial cells and the risk of AD/dementia by using Cox proportional hazards regression models after adjusting for covariates
Human Recombinant Monoclonal Anti Cd133 1 Rea753 Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/CD44+Antibody%2C+anti-human%2C+REAfinity/pmc09477743__41590_2022_1290_MOESM1_ESM-97-115-120
Average 95 stars, based on 1 article reviews
human recombinant monoclonal anti cd133 1 rea753 miltenyi biotec - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
anti cd133 apc  (Revvity)
97
Revvity anti cd133 apc
Examination of the relationship between different circulating progenitor or mature endothelial cells and the risk of AD/dementia by using Cox proportional hazards regression models after adjusting for covariates
Anti Cd133 Apc, supplied by Revvity, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/SureLight+Allophycocyanin-anti-6His+antibody%2C+lyophilized/pmc10296948-105-18-23
Average 97 stars, based on 1 article reviews
anti cd133 apc - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier
cd133 2 293c3 apc antibodies  (Miltenyi Biotec)
95
Miltenyi Biotec cd133 2 293c3 apc antibodies
Examination of the relationship between different circulating progenitor or mature endothelial cells and the risk of AD/dementia by using Cox proportional hazards regression models after adjusting for covariates
Cd133 2 293c3 Apc Antibodies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/CD133%2F2+Antibody%2C+anti-human/us08357492-135-16-19
Average 95 stars, based on 1 article reviews
cd133 2 293c3 apc antibodies - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
flow cd133 apc mouse miltenyi  (Miltenyi Biotec)
93
Miltenyi Biotec flow cd133 apc mouse miltenyi
Examination of the relationship between different circulating progenitor or mature endothelial cells and the risk of AD/dementia by using Cox proportional hazards regression models after adjusting for covariates
Flow Cd133 Apc Mouse Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/CD105+Antibody%2C+anti-mouse/pmc05727523__41598_2017_17884_MOESM1_ESM-35-81-84
Average 93 stars, based on 1 article reviews
flow cd133 apc mouse miltenyi - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
apc labeled anti cd133  (Cell Signaling Technology Inc)
93
Cell Signaling Technology Inc apc labeled anti cd133
Examination of the relationship between different circulating progenitor or mature endothelial cells and the risk of AD/dementia by using Cox proportional hazards regression models after adjusting for covariates
Apc Labeled Anti Cd133, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/APC+Antibody/pmc09172155-71-6-9
Average 93 stars, based on 1 article reviews
apc labeled anti cd133 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
anti human cd133  (Elabscience Biotechnology)
93
Elabscience Biotechnology anti human cd133
Examination of the relationship between different circulating progenitor or mature endothelial cells and the risk of AD/dementia by using Cox proportional hazards regression models after adjusting for covariates
Anti Human Cd133, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/APC+Anti-Human+CD133+Antibody/pm41414814-45-17-20
Average 93 stars, based on 1 article reviews
anti human cd133 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
prominin apc  (Miltenyi Biotec)
96
Miltenyi Biotec prominin apc
Examination of the relationship between different circulating progenitor or mature endothelial cells and the risk of AD/dementia by using Cox proportional hazards regression models after adjusting for covariates
Prominin Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd133+1+apc/Prominin-1+Antibody%2C+anti-mouse/bio_rxiv__64898__2026__02__19__706795-246-33-37
Average 96 stars, based on 1 article reviews
prominin apc - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

Image Search Results


Antibodies used for flow cytometry experiments.

Journal: PLoS ONE

Article Title: Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells

doi: 10.1371/journal.pone.0094621

Figure Lengend Snippet: Antibodies used for flow cytometry experiments.

Article Snippet: , PE or APC conjugated anti-human CD133/1 (Miltenyi Biotech, Germany).

Techniques: Flow Cytometry, Control

Examination of the relationship between different circulating progenitor or mature endothelial cells and the risk of AD/dementia by using Cox proportional hazards regression models after adjusting for covariates

Journal: Exploration of medicine

Article Title: The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer’s disease in the Framingham Heart Study

doi: 10.37349/emed.2024.00216

Figure Lengend Snippet: Examination of the relationship between different circulating progenitor or mature endothelial cells and the risk of AD/dementia by using Cox proportional hazards regression models after adjusting for covariates

Article Snippet: Then, PBMCs were isolated via Ficoll (General Electric) gradient centrifugation, counted, incubated with FcR blocking antibodies (Miltenyi Biotec), labeled with anti-human KDR PE antibody (R&D Systems), anti-human CD34 FITC antibody (BD Biosciences), anti-human CD133 APC antibody (BD Biosciences).

Techniques:

Detailed examination of the relationship between CD34+CD133+ (log-transformed) and the risk of AD/dementia risk

Journal: Exploration of medicine

Article Title: The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer’s disease in the Framingham Heart Study

doi: 10.37349/emed.2024.00216

Figure Lengend Snippet: Detailed examination of the relationship between CD34+CD133+ (log-transformed) and the risk of AD/dementia risk

Article Snippet: Then, PBMCs were isolated via Ficoll (General Electric) gradient centrifugation, counted, incubated with FcR blocking antibodies (Miltenyi Biotec), labeled with anti-human KDR PE antibody (R&D Systems), anti-human CD34 FITC antibody (BD Biosciences), anti-human CD133 APC antibody (BD Biosciences).

Techniques:

Characteristics of the study sample based on circulating CD34+CD133+ EPC quartiles

Journal: Exploration of medicine

Article Title: The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer’s disease in the Framingham Heart Study

doi: 10.37349/emed.2024.00216

Figure Lengend Snippet: Characteristics of the study sample based on circulating CD34+CD133+ EPC quartiles

Article Snippet: Then, PBMCs were isolated via Ficoll (General Electric) gradient centrifugation, counted, incubated with FcR blocking antibodies (Miltenyi Biotec), labeled with anti-human KDR PE antibody (R&D Systems), anti-human CD34 FITC antibody (BD Biosciences), anti-human CD133 APC antibody (BD Biosciences).

Techniques:

Survival analyses of circulating CD34+CD133+ cells for AD risk. Circulating the proportions (%) of CD34+CD133+ EPCs were divided into four quartiles based on the cell numbers (Q1 = 0.002–0.021; Q2 = 0.021–0.033; Q3 = 0.033–0.050; and Q4 = 0.050–0.609). Kaplan-Meier survival analysis was conducted to evaluate the survival-free time before AD over 14 years of follow-up to examine the relationship between CD34+CD133+ quartiles and AD incidence for: (A) all of the participants; (B) and (C) stratified based on the genotypes, (B) kirre like nephrin family adhesion molecule 3 (KIRREL3) rs4144611 major homozygotes TT vs. GG + TG; (C) KIRREL3 rs580382 major homozygotes CC vs. TT + CT, and (D) exocyst complex component 6B (EXOC6B) rs61619102 major homozygotes CC vs. GG + GC. P values are shown for statistical significance. Q: quartile

Journal: Exploration of medicine

Article Title: The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer’s disease in the Framingham Heart Study

doi: 10.37349/emed.2024.00216

Figure Lengend Snippet: Survival analyses of circulating CD34+CD133+ cells for AD risk. Circulating the proportions (%) of CD34+CD133+ EPCs were divided into four quartiles based on the cell numbers (Q1 = 0.002–0.021; Q2 = 0.021–0.033; Q3 = 0.033–0.050; and Q4 = 0.050–0.609). Kaplan-Meier survival analysis was conducted to evaluate the survival-free time before AD over 14 years of follow-up to examine the relationship between CD34+CD133+ quartiles and AD incidence for: (A) all of the participants; (B) and (C) stratified based on the genotypes, (B) kirre like nephrin family adhesion molecule 3 (KIRREL3) rs4144611 major homozygotes TT vs. GG + TG; (C) KIRREL3 rs580382 major homozygotes CC vs. TT + CT, and (D) exocyst complex component 6B (EXOC6B) rs61619102 major homozygotes CC vs. GG + GC. P values are shown for statistical significance. Q: quartile

Article Snippet: Then, PBMCs were isolated via Ficoll (General Electric) gradient centrifugation, counted, incubated with FcR blocking antibodies (Miltenyi Biotec), labeled with anti-human KDR PE antibody (R&D Systems), anti-human CD34 FITC antibody (BD Biosciences), anti-human CD133 APC antibody (BD Biosciences).

Techniques:

The relationship between circulating CD34+CD133+ cells and reduced AD risk in the presence of vascular diseases. The FHS participants were stratified into divided based on the CD34+CD133+ EPC proportion quartiles and further divided into those individuals with the absence or presence of different vascular diseases. In the absence of any peripheral and central vascular diseases (A, B), in the presence of CHD (C, D), HTN (E, F), stroke (G, H), silent infarcts (I, J), CMBs (K, L), and high WMHI (M, N), the numbers and percentages of incident AD (A, C, E, G, I, K, and M) and all-cause dementia (B, D, F, H, J, L, and N) across four CD34+CD133+ quartiles were examined by using Chi-squared test with indicated P values. Q: quartile

Journal: Exploration of medicine

Article Title: The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer’s disease in the Framingham Heart Study

doi: 10.37349/emed.2024.00216

Figure Lengend Snippet: The relationship between circulating CD34+CD133+ cells and reduced AD risk in the presence of vascular diseases. The FHS participants were stratified into divided based on the CD34+CD133+ EPC proportion quartiles and further divided into those individuals with the absence or presence of different vascular diseases. In the absence of any peripheral and central vascular diseases (A, B), in the presence of CHD (C, D), HTN (E, F), stroke (G, H), silent infarcts (I, J), CMBs (K, L), and high WMHI (M, N), the numbers and percentages of incident AD (A, C, E, G, I, K, and M) and all-cause dementia (B, D, F, H, J, L, and N) across four CD34+CD133+ quartiles were examined by using Chi-squared test with indicated P values. Q: quartile

Article Snippet: Then, PBMCs were isolated via Ficoll (General Electric) gradient centrifugation, counted, incubated with FcR blocking antibodies (Miltenyi Biotec), labeled with anti-human KDR PE antibody (R&D Systems), anti-human CD34 FITC antibody (BD Biosciences), anti-human CD133 APC antibody (BD Biosciences).

Techniques:

Comparisons of brain volumes across circulating CD34+CD133+ EPC quartiles

Journal: Exploration of medicine

Article Title: The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer’s disease in the Framingham Heart Study

doi: 10.37349/emed.2024.00216

Figure Lengend Snippet: Comparisons of brain volumes across circulating CD34+CD133+ EPC quartiles

Article Snippet: Then, PBMCs were isolated via Ficoll (General Electric) gradient centrifugation, counted, incubated with FcR blocking antibodies (Miltenyi Biotec), labeled with anti-human KDR PE antibody (R&D Systems), anti-human CD34 FITC antibody (BD Biosciences), anti-human CD133 APC antibody (BD Biosciences).

Techniques:

GWAS on the interactive effects of genetic factors and circulating CD34+CD133+ cells on AD risk. The FSH analytical pipeline was used to perform GWAS. The interaction between genome-wide SNP dosage and log-transformed proportions (%) of circulating CD34+CD133+ EPCs for AD risk was tested by using the GEEPACK model (logistic regression utilizing generalized estimating equations) adjusting for age, sex, years of education, and the first 10 PCs. As shown in the Manhattan plot, 8 SNPs showed significant interactions with CD34+CD133+ frequency on AD risk (A). Seven of the identified SNPs with a P value < 5.0 × 10 −8 originated from gene KIRREL3 on chromosome 11 (rs580382 and rs4144611 were selected for further analysis), and 1 of them originated from EXOC6B (chromosome 2, rs61619102). Only r 2 ≥ 0.1 and SNPs with MAF ≥ 10% were considered. Manhattan plot (A) was used for visualization to identify the genotypes of two genes ( KIRREL3 and EXOC6B ) that had interactive effects with CD34+CD133+ EPCs for AD risk. Gene structures, surrounding regions, and methylation sites of KIRREL3 (B) and EXOC6B (C) are presented by using LocusZoom

Journal: Exploration of medicine

Article Title: The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer’s disease in the Framingham Heart Study

doi: 10.37349/emed.2024.00216

Figure Lengend Snippet: GWAS on the interactive effects of genetic factors and circulating CD34+CD133+ cells on AD risk. The FSH analytical pipeline was used to perform GWAS. The interaction between genome-wide SNP dosage and log-transformed proportions (%) of circulating CD34+CD133+ EPCs for AD risk was tested by using the GEEPACK model (logistic regression utilizing generalized estimating equations) adjusting for age, sex, years of education, and the first 10 PCs. As shown in the Manhattan plot, 8 SNPs showed significant interactions with CD34+CD133+ frequency on AD risk (A). Seven of the identified SNPs with a P value < 5.0 × 10 −8 originated from gene KIRREL3 on chromosome 11 (rs580382 and rs4144611 were selected for further analysis), and 1 of them originated from EXOC6B (chromosome 2, rs61619102). Only r 2 ≥ 0.1 and SNPs with MAF ≥ 10% were considered. Manhattan plot (A) was used for visualization to identify the genotypes of two genes ( KIRREL3 and EXOC6B ) that had interactive effects with CD34+CD133+ EPCs for AD risk. Gene structures, surrounding regions, and methylation sites of KIRREL3 (B) and EXOC6B (C) are presented by using LocusZoom

Article Snippet: Then, PBMCs were isolated via Ficoll (General Electric) gradient centrifugation, counted, incubated with FcR blocking antibodies (Miltenyi Biotec), labeled with anti-human KDR PE antibody (R&D Systems), anti-human CD34 FITC antibody (BD Biosciences), anti-human CD133 APC antibody (BD Biosciences).

Techniques: Genome Wide, Transformation Assay, Methylation

Interactions between SNPs of KIRREL3 or EXOC6B and CD34+CD133+ on AD risk in FHS

Journal: Exploration of medicine

Article Title: The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer’s disease in the Framingham Heart Study

doi: 10.37349/emed.2024.00216

Figure Lengend Snippet: Interactions between SNPs of KIRREL3 or EXOC6B and CD34+CD133+ on AD risk in FHS

Article Snippet: Then, PBMCs were isolated via Ficoll (General Electric) gradient centrifugation, counted, incubated with FcR blocking antibodies (Miltenyi Biotec), labeled with anti-human KDR PE antibody (R&D Systems), anti-human CD34 FITC antibody (BD Biosciences), anti-human CD133 APC antibody (BD Biosciences).

Techniques:

The association between circulating CD34+CD133+ cells and the risk of AD in the context of genetic background

Journal: Exploration of medicine

Article Title: The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer’s disease in the Framingham Heart Study

doi: 10.37349/emed.2024.00216

Figure Lengend Snippet: The association between circulating CD34+CD133+ cells and the risk of AD in the context of genetic background

Article Snippet: Then, PBMCs were isolated via Ficoll (General Electric) gradient centrifugation, counted, incubated with FcR blocking antibodies (Miltenyi Biotec), labeled with anti-human KDR PE antibody (R&D Systems), anti-human CD34 FITC antibody (BD Biosciences), anti-human CD133 APC antibody (BD Biosciences).

Techniques: